世界最新医学信息文摘（电子版）
世界最新醫學信息文摘（電子版）
세계최신의학신식문적（전자판）
World Latest Medicine Information
2014年
22期
36-37
,共2页
原发性肝癌%螺旋ct%诊断临床%干预
原髮性肝癌%螺鏇ct%診斷臨床%榦預
원발성간암%라선ct%진단림상%간예
primary liver cancer%spiral CT%diagnosis%intervention
目的：探讨原发性肝癌螺旋ct诊断对临床早期干预治疗的价值。方法将54例肝癌患者随机分为治疗组与对照组各23例。两组患者均经螺旋ct做出诊断，两组均进行常规化疗、放疗方案。治疗组在此基础上，辅助应用复肝汤（主要药物：郁金、大黄、赤芍、半枝莲、白花蛇舌草等），治疗组复肝汤从化疗开始运用，直至放疗结束。结果所有患者都要应用ct多期增强检查，检查出来病灶全部有113个，病灶范围5cm×5cm×4cm～22cm×17cm×16cm；经临床干预治疗后，治疗组症状、体征明显改善，不良反应发生率低，1年生存率为91.30%，对照组为69.57%，两组比较有显著性差异（△P＜0.05）。结论原发性肝癌行螺旋ct的诊断，对临床早期干预治疗具有显著的意义。
目的：探討原髮性肝癌螺鏇ct診斷對臨床早期榦預治療的價值。方法將54例肝癌患者隨機分為治療組與對照組各23例。兩組患者均經螺鏇ct做齣診斷，兩組均進行常規化療、放療方案。治療組在此基礎上，輔助應用複肝湯（主要藥物：鬱金、大黃、赤芍、半枝蓮、白花蛇舌草等），治療組複肝湯從化療開始運用，直至放療結束。結果所有患者都要應用ct多期增彊檢查，檢查齣來病竈全部有113箇，病竈範圍5cm×5cm×4cm～22cm×17cm×16cm；經臨床榦預治療後，治療組癥狀、體徵明顯改善，不良反應髮生率低，1年生存率為91.30%，對照組為69.57%，兩組比較有顯著性差異（△P＜0.05）。結論原髮性肝癌行螺鏇ct的診斷，對臨床早期榦預治療具有顯著的意義。
목적：탐토원발성간암라선ct진단대림상조기간예치료적개치。방법장54례간암환자수궤분위치료조여대조조각23례。량조환자균경라선ct주출진단，량조균진행상규화료、방료방안。치료조재차기출상，보조응용복간탕（주요약물：욱금、대황、적작、반지련、백화사설초등），치료조복간탕종화료개시운용，직지방료결속。결과소유환자도요응용ct다기증강검사，검사출래병조전부유113개，병조범위5cm×5cm×4cm～22cm×17cm×16cm；경림상간예치료후，치료조증상、체정명현개선，불량반응발생솔저，1년생존솔위91.30%，대조조위69.57%，량조비교유현저성차이（△P＜0.05）。결론원발성간암행라선ct적진단，대림상조기간예치료구유현저적의의。
Objective to study the value of spiral ct in the diagnosis of primary liver cancer in the clinical treatment of early intervention.Methods 54 cases of liver cancer were randomly divided into treatment group and control group with 23 cases in each. two groups of patients were all diagnosed by spiral ct and they were all received routine chemotherapy and radiotherapy. While patients in the treatment group were given fugan decoction (main drug: turmeric, radix paeoniae rubra, rhubarb, scutellaria barbata, Hedyotis diffusa etc.) based on the routine treatment and fugan decoction was taken in the treatment group from the start of chemotherapy till to the end of radiotherapy.Results the enhancement ct examination were applied for all the patients, from which 113 lesions were checked out and the lesions ranged from 5cm * 5cm * 4cm to 22cm * 17cm * 16cm. after the clinical intervention treatment, the symptoms and signs were improved in the treatment group with low incidence of adverse reactions. and the 1 year survival rate was 91.30%, which was 69.57% in control group. there were signiifcant difference between two groups (P < 0.05). diagnosis with spiral ct in primary hepatocellular carcinoma has signiifcant meaning for the clinical treatment of early intervention.
